| Q90581317 | A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer's disease |
| Q92688434 | A pilot study of fluorescence lifetime imaging ophthalmoscopy in preclinical Alzheimer's disease |
| Q42281478 | Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. |
| Q41825866 | Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease |
| Q37985523 | Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment |
| Q38885797 | Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo. |
| Q36236460 | Analysis of Retinal Peripapillary Segmentation in Early Alzheimer's Disease Patients |
| Q33915815 | Analysis of macular OCT images using deformable registration. |
| Q55076072 | Application of Optical Coherence Tomography in the Detection and Classification of Cognitive Decline. |
| Q37011166 | Assessment of candidate ocular biomarkers of ageing in a South African adult population: relationship with chronological age and systemic biomarkers |
| Q92267906 | Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor |
| Q27000410 | At the interface of sensory and motor dysfunctions and Alzheimer's disease |
| Q36790844 | BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease |
| Q34743196 | Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients |
| Q47158889 | Cerebral and Retinal Neurovascular Changes: A Biomarker for Alzheimer's Disease |
| Q55026294 | Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease. |
| Q92638553 | Changes in visual function and retinal structure in the progression of Alzheimer's disease |
| Q39413668 | Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function |
| Q36919235 | Cognitive decline and dementia in the oldest-old |
| Q37394858 | Comparison of visual evoked potentials and retinal nerve fiber layer thickness in Alzheimer's disease. |
| Q37602032 | Detection of Retinal Nerve Fiber Layer Defects in Alzheimer's Disease Using SD-OCT. |
| Q57642468 | Editors’ Introduction |
| Q39113804 | Emerging ocular biomarkers of Alzheimer disease. |
| Q50114264 | Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease |
| Q51280846 | Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography. |
| Q57138468 | Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry |
| Q90932818 | Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET |
| Q38580403 | How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis? |
| Q92027877 | Identification of Retinal Biomarkers in Alzheimer's Disease Using Optical Coherence Tomography: Recent Insights, Challenges, and Opportunities |
| Q61805640 | Integrated Cognitive Assessment: Speed and Accuracy of Visual Processing as a Reliable Proxy to Cognitive Performance |
| Q39416419 | Is there a link between open-angle glaucoma and dementia? The Three-City-Alienor cohort |
| Q34541965 | Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice |
| Q35996957 | Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease |
| Q64892449 | Macular and Retinal Nerve Fibre Layer Thinning in Xeroderma Pigmentosum: A Cross-sectional Study. |
| Q36533171 | Melanopsin retinal ganglion cell loss in Alzheimer disease |
| Q92476232 | Mercury in the retina and optic nerve following prenatal exposure to mercury vapor |
| Q26765764 | Meta-analysis of the relationship of peripheral retinal nerve fiber layer thickness to Alzheimer's disease and mild cognitive impairment |
| Q38741574 | Multiple-object geometric deformable model for segmentation of macular OCT |
| Q28078670 | Ocular indicators of Alzheimer's: exploring disease in the retina |
| Q38533327 | Oculo-visual changes and clinical considerations affecting older patients with dementia |
| Q38212813 | Ophthalmic manifestations of inherited neurodegenerative disorders |
| Q35708602 | Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease. |
| Q35912687 | Ophthalmology issues in schizophrenia |
| Q39010375 | Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease |
| Q47221811 | Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. |
| Q35740076 | Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis |
| Q38823817 | Optical coherence tomography and neurodegeneration: are eyes the windows to the brain? |
| Q30597564 | Optical coherence tomography as a biomarker in multiple sclerosis |
| Q37406826 | Optical coherence tomography findings in spinocerebellar ataxia-3. |
| Q34238794 | Optical coherence tomography in parkinsonian syndromes |
| Q92239941 | Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases |
| Q49761625 | Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies |
| Q61799359 | Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Alzheimer's Disease: A Comparison of Eyes of Patients with Alzheimer's Disease, Primary Open-Angle Glaucoma, and Preperimetric Glaucoma and Healthy Controls |
| Q90215258 | Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases |
| Q55480248 | Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review. |
| Q91741157 | Reduced Retinal Thickness Predicts Age-Related Changes in Cognitive Function |
| Q91944498 | Reflections on the Utility of the Retina as a Biomarker for Alzheimer's Disease: A Literature Review |
| Q41436471 | Repeatability and Reproducibility of Retinal Neuronal and Axonal Measures on Spectral-Domain Optical Coherence Tomography in Patients with Cognitive Impairment |
| Q48897414 | Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia |
| Q41845723 | Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease |
| Q91936690 | Retinal correlates of neurological disorders |
| Q33902900 | Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry |
| Q35497863 | Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease |
| Q38237224 | Retinal manifestations of Alzheimer's disease |
| Q36214568 | Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases |
| Q37670223 | Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis. |
| Q51760905 | Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology. |
| Q33988188 | Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1 |
| Q28070142 | The Eye As a Biomarker for Alzheimer's Disease |
| Q47095979 | The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies. |
| Q34298350 | The optic nerve: a "mito-window" on mitochondrial neurodegeneration |
| Q50602202 | The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. |
| Q28079500 | The role of optical coherence tomography in Alzheimer's disease |
| Q35128118 | Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease. |
| Q47961640 | Using Retinal Imaging to Study Dementia |
| Q58567916 | Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview |
| Q26752621 | Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression |
| Q39013852 | Visual system manifestations of Alzheimer's disease |
| Q39339989 | Visual system pathology in humans and animal models of blast injury |
| Q36908647 | Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings |